Sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors on in-hospital mortality following pneumonia without heart failure: A retrospective cohort study of older adults with diabetes

Autor:	Maki, Hiroki, Isogai, Toshiaki, Michihata, Nobuaki, Matsui, Hiroki, Fushimi, Kiyohide, Yasunaga, Hideo
Zdroj:	Respiratory Investigation; January 2025, Vol. 63 Issue: 1 p88-93, 6p
Abstrakt:	Sodium-glucose co-transporter-2 inhibitors (SGLT2i) may contribute to better clinical outcomes in adults with diabetes and pneumonia owing to their potential anti-inflammatory effects. To investigate whether SGLT2i are associated with lower in-hospital mortality following pneumonia without heart failure than dipeptidyl peptidase-4 inhibitors (DPP-4i).
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect